Largest biotech companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Amgen leads the 24 biotech companies ranked by cash on hand, at SEK 92.8B, ahead of BioNTech (SEK 86.6B) and Gilead Sciences (SEK 76.9B). Figures as of 18 Nov 2026, 21:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenSEK 92.8B
- Median
- SEK 4.4B
- Combined market value
- SEK 8.5T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | SEK 92.8B | SEK 2.44T | SEK 4,511.88 | 3.07% down | 34% up | ||
| 2 | BioNTechBNTX · Health Care | SEK 86.6B | SEK 209.8B | SEK 846.29 | 1.89% down | 16% down | ||
| 3 | Gilead SciencesGILD · Health Care | SEK 76.9B | SEK 2.13T | SEK 1,717.58 | 0.75% down | 33% up | ||
| 4 | argenxARGX · Health Care | SEK 35.5B | SEK 601.6B | SEK 9,567.26 | 0.66% down | 4% up | ||
| 5 | BiogenBIIB · Health Care | SEK 30.6B | SEK 377.7B | SEK 2,555.44 | 0.25% up | 49% up | ||
| 6 | ModernaMRNA · Health Care | SEK 26.4B | SEK 809.3B | SEK 2,000.26 | 4.84% down | 755% up | ||
| 7 | ImmunovantIMVT · Health Care | SEK 9.2B | SEK 69.8B | SEK 337.15 | 0.12% down | 43% up | ||
| 8 | QiagenQGEN · Health Care | SEK 8.5B | SEK 104B | SEK 503.75 | 0.38% down | 12% up | ||
| 9 | Neurocrine BiosciencesNBIX · Health Care | SEK 7.2B | SEK 167.6B | SEK 1,655.38 | 1.84% down | 20% up | ||
| 10 | RepligenRGEN · Health Care | SEK 5.8B | SEK 112.2B | SEK 1,755.09 | 6.47% up | 5% up | ||
| 11 | Krystal BiotechKRYS · Health Care | SEK 5B | SEK 95B | SEK 3,205.25 | 5.62% up | 46% up | ||
| 12 | ExelixisEXEL · Health Care | SEK 4.9B | SEK 169.4B | SEK 694.13 | 0.31% down | 63% up | ||
| 13 | Revolution MedicinesRVMD · Health Care | SEK 3.9B | SEK 351.4B | SEK 1,624.48 | 1.76% down | 131% up | ||
| 14 | Kymera TherapeuticsKYMR · Health Care | SEK 3.6B | SEK 105.1B | SEK 1,231.22 | 0.32% down | 87% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | SEK 3.5B | SEK 39.6B | SEK 408.51 | 0.10% up | 21% down | ||
| 16 | Scholar Rock HoldingSRRK · Health Care | SEK 3.3B | SEK 59.5B | SEK 487.89 | 6.48% up | 14% up | ||
| 17 | Bio-TechneTECH · Health Care | SEK 2.7B | SEK 116.2B | SEK 739.46 | 0.17% up | 26% up | ||
| 18 | Kodiak SciencesKOD · Health Care | SEK 2.1B | SEK 65B | SEK 994.18 | 1.04% up | 396% up | ||
| 19 | Twist BioscienceTWST · Health Care | SEK 1.9B | SEK 80.6B | SEK 1,182.63 | 3.88% up | 340% up | ||
| 20 | VaxcytePCVX · Health Care | SEK 1.8B | SEK 94.2B | SEK 594.82 | 1.48% down | 22% up | ||
| 21 | Halozyme TherapeuticsHALO · Health Care | SEK 1.4B | SEK 111B | SEK 973.75 | 0.18% down | 37% up | ||
| 22 | ImmunityBioIBRX · Health Care | SEK 897.9M | SEK 72.4B | SEK 68.10 | 7.03% up | 193% up | ||
| 23 | Adaptive BiotechnologiesADPT · Health Care | SEK 716.5M | SEK 46.8B | SEK 289.28 | 0.11% down | 88% up | ||
| 24 | CG OncologyCGON · Health Care | SEK 330.2M | SEK 72.6B | SEK 813.15 | 1.34% up | 85% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1644 SEK).
Questions and answers
Which biotech companies rank first by cash on hand?
Amgen (SEK 92.8B), BioNTech (SEK 86.6B) and Gilead Sciences (SEK 76.9B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 21:48 UTC.
How many biotech companies are in this ranking?
24 are ranked by cash on hand.
What are these biotech companies worth together?
The 24 biotech companies ranked by cash on hand have a combined market value of SEK 8.5T as of 18 Nov 2026, 21:48 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.